Orange, CA4 Active Studies

Hemophilia Clinical Trials in Orange, CA

Find 4 actively recruiting hemophilia clinical trials in Orange, CA. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
470
Enrolling

Recruiting Hemophilia Studies in Orange

NCT07416604Recruiting

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of NXT007 prophylaxis compared with emicizumab prophylaxis in people age 12 years and older with s...

Orange, CAPHASE3360 participantsHoffmann-La Roche
View Study Details
NCT07285460Recruiting

A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B

This is a parallel, Phase 3, two-arm, open-label study to evaluate the efficacy and safety of treatment with fitusiran prophylaxis administered to male pediatric participants (aged 1 to \<12 years) wh...

Orange, CAPHASE385 participantsSanofi
View Study Details
NCT07080905Recruiting

Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B

This is a phase 3, prospective, open-label, single-arm, single-dose, multicenter study investigating the efficacy, safety, and tolerability of CSL222 (AAV5-hFIXco-Padua) in adolescent male participant...

Orange, CAPHASE320 participantsCSL Behring
View Study Details
NCT07226206Recruiting

A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A

This study will assess the safety and tolerability of SPK-8011QQ in adult males with moderately severe to severe hemophilia A....

Orange, CAPHASE15 participantsHoffmann-La Roche
View Study Details

About Hemophilia Clinical Trials in Orange

Hemophilia is a rare genetic bleeding disorder in which blood does not clot properly due to deficiency of clotting factors. Hemophilia A (factor VIII) and hemophilia B (factor IX) are the most common types. Treatment includes factor replacement therapy and newer approaches like gene therapy.

There are currently 4 hemophilia clinical trials recruiting participants in Orange, CA. These studies are seeking a combined 470 participants. Research is being sponsored by Hoffmann-La Roche, Sanofi, CSL Behring. Clinical trial participation is free and participants receive study-related medical care at no cost.

Hemophilia Clinical Trials in Orange — FAQ

Are there hemophilia clinical trials in Orange?

Yes, there are 4 hemophilia clinical trials currently recruiting in Orange, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Orange?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Orange research site will contact you about next steps.

Are clinical trials in Orange free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Orange studies also compensate for your time and travel.

What hemophilia treatments are being tested?

The 4 active trials in Orange are testing new therapies including novel drugs, biologics, and treatment approaches for hemophilia.

Data updated October 15, 2026 from ClinicalTrials.gov